Skip to content
healthcare.dev

GUNA KIDNEY PLUS

NDC 17089-474, calcium sulfide - chondrodendron tomentosum root - equisetum hyemale - sus scrofa pituitary gland - apis mellifera - urtica urens - sodium chloride - lobaria pulmonaria - horse chestnut - berberis vulgaris fruit - solidago viragaurea flowering top -, solution/ drops, from Guna spa.

Product NDC
17089-474
Status
Listed
Labeler
Guna spa
Dosage form
SOLUTION/ DROPS
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17089-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM SULFIDE6 [hp_X]/30mL
  • EQUISETUM HYEMALE3 [hp_X]/30mL
  • SUS SCROFA PITUITARY GLAND200 [hp_X]/30mL
  • APIS MELLIFERA12 [hp_X]/30mL
  • CHONDRODENDRON TOMENTOSUM ROOT4 [hp_X]/30mL
  • SODIUM CHLORIDE10 [hp_X]/30mL
  • LOBARIA PULMONARIA6 [hp_X]/30mL
  • HORSE CHESTNUT2 [hp_X]/30mL
  • BERBERIS VULGARIS FRUIT3 [hp_X]/30mL
  • SOLIDAGO VIRGAUREA FLOWERING TOP2 [hp_X]/30mL
  • URTICA URENS6 [hp_X]/30mL

Pharmacologic classes

Allergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Standardized Insect Venom Allergenic Extract [EPC]

Package NDCNDC-11Package
17089-474-18170890474181 BOTTLE, DROPPER in 1 BOX (17089-474-18) / 30 mL in 1 BOTTLE, DROPPER

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17089-474 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17089-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17089-474. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.